Skip to main content
. 2019 Oct 2;33(1):9–35. doi: 10.1007/s40620-019-00650-x

Fig. 2.

Fig. 2

Recommended usage and dosage of currently available non-insulin drugs according to the level of eGFR. eGFR estimated glomerular filtration rate, DPP-4 dipeptidyl peptidase 4, GLP-1 glucagon-like peptide 1, SGLT2 sodium-glucose cotransporter 2